Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-17-006527

Principal Financial Officer bought 3,500 shares at $1.17 ($4,095)

From the SEC's structured data for this filing

Trades in this filing

O'Loughlin Steve · Principal Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-06-15 Purchase : show line 1 in the form +3,500 $1.17 $4,095 3,500 D
Open-market purchases · 3,500 sh · avg $1.17 · $4,095
Loading xslF345X03/f4061517oloughlin_actinium.xml…